Amol Mehta, MD (@amolmehtamd) 's Twitter Profile
Amol Mehta, MD

@amolmehtamd

Neuroendovascular Surgery Fellow @MountSinai former @Columbianeuron Interested in: Neurointervention, Stroke, Public Health, Jazz Saxophone

ID: 803458464

calendar_today04-09-2012 23:56:19

214 Tweet

304 Takipçi

346 Takip Edilen

Amol Mehta, MD (@amolmehtamd) 's Twitter Profile Photo

Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours | New England Journal of Medicine nejm.org/doi/full/10.10…

JNIS (@jnis_bmj) 's Twitter Profile Photo

Is there any field of neurosurgery that endovascular intervention can't help? This series demonstrates the promise of endovascular embolization as refractory epilepsy treatment when anatomic or medical considerations preclude traditional surgery bit.ly/4dX3fmi

Is there any field of neurosurgery that endovascular intervention can't help?  This series demonstrates the promise of endovascular embolization as refractory epilepsy treatment when anatomic or medical considerations preclude traditional surgery bit.ly/4dX3fmi
Mount Sinai Neurosurgery (@mountsinaineuro) 's Twitter Profile Photo

At #SNIS2025! 🚨 Amol Mehta, MD, #Neuroendovascular surgery fellow at Mount Sinai Cerebrovascular & Mount Sinai Neurosurgery, presents “Beyond the First Pass Effect!" His talk explores how inter-pass time impacts #Stroke procedure success. Research mentored by Shahram Majidi, MD. SNIS Info #Neurosurgery

At #SNIS2025! 🚨 <a href="/AmolMehtaMD/">Amol Mehta, MD</a>, #Neuroendovascular surgery fellow at <a href="/MountSinaiCVC/">Mount Sinai Cerebrovascular</a> &amp; <a href="/MountSinaiNeuro/">Mount Sinai Neurosurgery</a>, presents “Beyond the First Pass Effect!" His talk explores how inter-pass time impacts #Stroke procedure success. Research mentored by <a href="/MajidiShahram/">Shahram Majidi, MD</a>. <a href="/SNISinfo/">SNIS Info</a> #Neurosurgery
JNIS (@jnis_bmj) 's Twitter Profile Photo

How do you assess liquid embolic penetration in MMA embolization? Dr. Daryl Goldman shows the SLEEK grading system shows deeper penetration leads to faster cSDH resolution. #snis2025 @SNISInfo ESMINT Society CV Section Felipe C. Albuquerque Michael Chen, MD Dr. DiestroKE Matthew Amans

How do you assess liquid embolic penetration in MMA embolization?  Dr. Daryl Goldman shows the SLEEK grading system shows deeper penetration leads to faster cSDH resolution. #snis2025 @SNISInfo <a href="/esmintsociety/">ESMINT Society</a> <a href="/cvsection/">CV Section</a> <a href="/fcalbuquerque51/">Felipe C. Albuquerque</a> <a href="/dr_mchen/">Michael Chen, MD</a> <a href="/DanniDiestro/">Dr. DiestroKE</a> <a href="/MattAmansMD/">Matthew Amans</a>
Amol Mehta, MD (@amolmehtamd) 's Twitter Profile Photo

“even with modern prevention therapy, the residual recurrence risk after AF-related stroke is high, with an estimated 1 in 6 patients experiencing a recurrent ischemic stroke at 5 years.” jamanetwork.com/journals/jaman…

Neurology Journal (@greenjournal) 's Twitter Profile Photo

This study provides Class IV evidence that in patients with basilar artery occlusion, selection for endovascular therapy (EVT) using noncontrast CT yields similar clinical and safety outcomes compared with selection for EVT using CT perfusion: hubs.la/Q03z8CSX0 #NeuroX

This study provides Class IV evidence that in patients with basilar artery occlusion, selection for endovascular therapy (EVT) using noncontrast CT yields similar clinical and safety outcomes compared with selection for EVT using CT perfusion: hubs.la/Q03z8CSX0

#NeuroX
Amol Mehta, MD (@amolmehtamd) 's Twitter Profile Photo

Being a senior fellow is sweett. TICI3 1 pass, 7 min groin puncture to recanalization! With Zoom 7X and CDAT! Imperative Care Vascular under the auspices of Shahram Majidi, MD NIHSS 7->1 and no infarct on MRI

Amol Mehta, MD (@amolmehtamd) 's Twitter Profile Photo

Thrilled to publish this piece in Stroke AHA/ASA alongside several of my mentors to hopefully clarify current dilemmas on the treatment of M2 occlusions, and to encourage the community to treat proximal/dominant M2s in the post MEVO trial era.

Thrilled to publish this piece in <a href="/StrokeAHA_ASA/">Stroke AHA/ASA</a> alongside several of my mentors to hopefully clarify current dilemmas on the treatment of M2 occlusions, and to encourage the community to treat proximal/dominant M2s in the post MEVO trial era.